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BJC moves forward
The British Journal of Cancer wishes all readers and contributors a happy and productive
New Year. BJC continues to broaden its range and strengthen its international base
as a high ranking journal in cancer research. It encompasses clinical, epidemiological
and experimental research. Our relatively new section on Genetics and Genomics is
growing and BJC as a whole has increased its impact rating and high quality. We are
expanding our editorial comment and we are pleased that readers particularly value
the concise and incisive short reviews on the latest advances in cancer research.
Starting with this issue, we are pleased to announce a new publisher, Nature
Publishing Group. NPG will provide a dynamic publishing environment in which BJC
has a pivotal place among NPG’s cancer journals. Nature’s news services and Nature
Cancer Update will facilitate access to numerous developments in cancer research as well
as ease of cross-referral. We look forward to rapid development of on-line submission
and processing of research papers and to increasing our editorial and review content.
Improved production times and on-line availability will beneﬁt authors and readers alike.
In February the owner of BJC, The Cancer Research Campaign, will merge with the
Imperial Cancer Research Fundto form ‘CancerResearch UK’. The new organization will be
the world’s largest cancer research charity, combining complementary strengths to advance
the treatment of cancer patients and, no less importantly, to understand the nature and
causes of cancer, and to prevent it. From this exciting development BJC will gain strength
while maintaining its independent outward looking, international scope and reputation for
novelty combined with reliability.
Robin A Weiss
Editor-in-Chief
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